drugset / Trial / NCT01330238

The Efficacy of Zoledronic Acid in Modic Changes-related Low Back Pain (LBP)

NCT01330238

RandomizedParallel-groupQuadruple-blindTreatment

Summary

Modic changes are associated with low back pain (LBP) both in clinical and general population-based samples. Type I changes are regarded as more likely to be painful than type II changes. Several studies suggest that type I changes are inflammatory in nature.

Timeline

Start
2008-12
Primary completion
2011-03
Completion
2012-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Zoledronic acid Other / unclassified 5 mg Intravenous

Indications

No indication recorded.